MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from redemptions of cas...
Net income
Extension deposits
Proceeds from interim note
Negative Cash Flow Breakdown
Payment to ordinary shareholders...
Interest earned on cash and inve...
Investment of cash into trust ac...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Payment of operating costs through promissory note
0
0
27,300
114,676
Net income
1,726,897
1,970,459
212,958
2,184,563
Share issuance expense
-
-
1,996,000
-
Capital contribution for cancellation of administrative support fee
0
30,000
-
-
Interest earned on cash and investments held in trust account
1,863,831
2,113,760
2,302,424
2,448,266
Prepaid expenses
48,904
-6,054
-21,425
-21,425
Accounts payable and accrued expenses
-58,769
15,997
-80,439
155,170
Net cash used in operating activities
-244,607
-91,250
-125,180
-56,108
Investment of cash into trust account
600,000
0
0
0
Proceeds from redemptions of cash in trust account
99,311,220
-
-
-
Net cash provided by (used in) investing activities
98,711,220
0
0
0
Proceeds from sale of units, net of underwriting discounts paid
0
0
0
228,850,000
Proceeds from sale of private placement units
0
0
0
0
Expenses paid by sponsor under share subscription receivable
0
0
-130,600
-410,178
Repayment of promissory note - related party
0
0
0
0
Payment of offering costs
0
0
-
-
Proceeds from interim note
250,000
100,000
-
-
Payment to ordinary shareholders for redemptions
99,311,220
-
-
-
Payment of offering costs
-
-
0
0
Extension deposits
600,000
-
-
-
Net cash (used in) provided by financing activities
-98,461,220
100,000
130,600
56,003
Net change in cash
-
8,750
-
-
Net change in cash
5,393
8,750
5,420
-105
Cash beginning of period
717
717
-
1,351
Cash end of period
20,280
14,887
-
717
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from
redemptions of cash in trust...
$99,311,220
Net cash provided by
(used in) investing...
$98,711,220
(142.70%↑ Y/Y)
Canceled cashflow
$600,000
Net change in cash
$5,393
(1119.47%↑ Y/Y)
Canceled cashflow
$98,705,827
Investment of cash into
trust account
$600,000
(-99.74%↓ Y/Y)
Extension deposits
$600,000
Proceeds from interim
note
$250,000
Net income
$1,726,897
(-51.26%↓ Y/Y)
Net cash (used in)
provided by financing...
-$98,461,220
(-142.53%↓ Y/Y)
Net cash used in
operating activities
-$244,607
(31.65%↑ Y/Y)
Canceled cashflow
$850,000
Canceled cashflow
$1,726,897
Payment to ordinary
shareholders for redemptions
$99,311,220
Interest earned on cash
and investments...
$1,863,831
(-53.47%↓ Y/Y)
Accounts payable and
accrued expenses
-$58,769
(-183.75%↓ Y/Y)
Prepaid expenses
$48,904
(0.00%↑ Y/Y)
Buy us a coffee
Drugs Made In America Acquisition Corp. (DMAAU)
Drugs Made In America Acquisition Corp. (DMAAU)